Browse investments

Invest in Spyre Therapeutics Inc on Stash

Spyre Therapeutics Inc is a clinical-stage biotechnology company

To buy fractional shares of Spyre Therapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: SYRE

Spyre Therapeutics Inc

$31.53

+3.11%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

SYRE Performance Breakdown

Share Price

$31.53

Today's change

-3.87%

Year to date change (YTD)

3.11%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About SYRE

Spyre Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its product candidate is Pegtarviliase, a novel polyethylene glycol modified (PEGylated), human enzyme engineered to reduce elevated levels of total homocysteine circulating in the plasma. It has engineered pegtarviliase by directed mutagenesis of amino acids within the wild-type human cystathionine y-lyase enzyme (CGL). The Company’s second product candidate Pegzilarginase is a PEGylated, recombinant human arginase 1 that enzymatically degrades the amino acid arginine to lower arginine levels in patients with Arginase 1 Deficiency. It has engineered pegzilarginase with modifications that enhance arginine-degrading activity of the enzyme in human plasma. The Company is engaged in advancing inflammatory bowel disease (IBD) portfolio which consists of SPY001 and SPY002, antibody candidates.

Spyre Therapeutics Inc Stock Ticker

SYRE

For more information

https://spyre.com/

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Spyre Therapeutics Inc on Stash

Spyre Therapeutics Inc is a clinical-stage biotechnology company

To buy fractional shares of Spyre Therapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Spyre Therapeutics Inc stock news

CNBC

JPMorgan Chase is set to report fourth-quarter earnings – here's what the Street expects

JPMorgan Chase reports fourth-quarter earnings before the market open Tuesday. Wall Street expects earnings of $5 a share and revenue of $46.2 billion, according to LSEG.

about 17 hours ago

24/7 Wall Street

Up 96% in Just 1 Month, Is Planet Labs Now Too Pricey to Buy?

Planet Labs ( NYSE:PL ) has been on a tear, soaring 388% in 2025 and up another 96% since reporting earnings one month ago.

about 8 hours ago

Business Insider

Meta shakes up its review system with 'stronger rewards for top performers'

Meta unveils new Checkpoint performance program with higher bonuses for top employees. The updated system introduces four performance ratings and rewards exceptional impact at Meta.

about 23 hours ago

CNBC

JPMorgan Chase says banks could fight Trump credit card rate cap: 'Everything's on the table'

JPMorgan Chase CFO Jeremy Barnum said the industry could fight President Donald Trump's demand for credit card price controls. Banks and industry insiders say a proposed 10% cap on credit card interest rates would result in fewer credit card accounts for Americans and a dip in spending for the U.S. economy.

about 8 hours ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Spyre Therapeutics Inc stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Spyre Therapeutics Inc’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Spyre Therapeutics Inc’s price can fluctuate throughout the course of each trading day—when you buy Spyre Therapeutics Inc through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Spyre Therapeutics Inc stock price and the Spyre Therapeutics Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers two subscription plans: Stash Growth and Stash+.

Each plan can help you reach different goals and offers a unique combination of financial accounts and features. All plans include access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Spyre Therapeutics Inc stock is complete, you'll officially be a shareholder of Spyre Therapeutics Inc!